Dangsim K-7 (Korea Genetic Pharm Co., Ltd)
Welcome to the PulseAid listing for the Dangsim K-7 drug offered from Korea Genetic Pharm Co., Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Korea Genetic Pharm Co., Ltd |
NON-PROPRIETARY NAME: | MOMORDICA CHARANTIA FRUIT |
SUBSTANCE NAME: | MOMORDICA CHARANTIA FRUIT |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | GRANULE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-02-07 |
END MARKETING DATE: | 0000-00-00 |
Dangsim K-7 HUMAN OTC DRUG Details:
Item Description | Dangsim K-7 from Korea Genetic Pharm Co., Ltd |
LABELER NAME: | Korea Genetic Pharm Co., Ltd |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 13(g/100g) |
START MARKETING DATE: | 2012-02-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42707-1001_daca2668-d76f-4e0f-b7da-3224ffffdbae |
PRODUCT NDC: | 42707-1001 |
APPLICATION NUMBER: | |
Other MOMORDICA CHARANTIA FRUIT Pharmaceutical Manufacturers / Labelers: